chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1408-Pt called dtr and stated "I am not sure if I am having a panic attack". EMT was called. After evaluation by EMT pt was released at 1418 by EMT.
Became fussy not herself, irritable not laughing smiling, not falling asleep occurred x 3 days and now is acting normal.
Vaccine related error. Patient received wrong age specific COVID-19 vaccine formulation. Received formulation for 6mos-4yrs instead of 5yrs-11yrs formulation. Parents opted not to re-dose with COVID-19 vaccine at this time.
The patient was very cranky 2 days after receiving vaccination. A fever was not noticed until the third day. The fever of 101F lasted 3 days. A week post-vax the patient developed a rash all over his body, except arms, legs and face. There were more than 50 spots, very bad behind his ears and on his scalp. These symptoms lasted more than a week. The pediatrician diagnosed reaction to MMR vaccine. The patient was treated with Tylenol and Benadryl.
Tingling in index finger; Pain at injection site; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 29Jan2021 (Lot number: EL9209) at the age of 42 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Type 2 Diabetes" (unspecified if ongoing). Concomitant medication(s) included: METFORMIN; FISH OIL; CHOLECALCIFEROL. The following information was reported: PARAESTHESIA (non-serious), outcome "unknown", described as "Tingling in index finger"; VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "Pain at injection site".  Additional information: First dose had pain at injection site with approximately a 4-5 inch radius .  No follow-up attempts are possible. No further information is expected.
Vaccine was given on 9/2/2020 but the vaccine was 1 day expired with expiration date of 9/1/2020.
Nauseous; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot Number: Unknown), via an unspecified route of administration on an unspecified date at a single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced nauseous on an unspecified date. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
The child has severe seizures and an extremely irregular brain pattern (video EEG done) with limited ability to speak and function because of the severity of the seizures.
Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about concurrent conditions, medical history and concomitant medication was not provided. On 25-JAN-2016 the patient was administered with a dose of improperly stored ROTATEQ (lot# L013203 and expiration date 28-JAN-2017, dose, dose# and route not reported) and RECOMBIVAX HB (lot# L027733 and expiration date 13-SEP-2017, dose, dose# and route not reported). No adverse effects reported. This is one of several reports received from the same source. Additional information is not expected since there was no consent for follow up contact.
arm is been little sore/ pain in arms/ pain in the thumb; pain in wrist; pain in muscles; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "arm is been little sore/ pain in arms/ pain in the thumb"; ARTHRALGIA (non-serious), outcome "unknown", described as "pain in wrist"; MYALGIA (non-serious), outcome "unknown", described as "pain in muscles".  Additional Information: The patient mentioned that he needs to reschedule the second dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I had no reaction to my first two Pfizer COVID vaccines in Dec 2020 and January 2021 other than a very sore arm (worse than other vaccines). I received my booster on October 11 2021 and had a very sore arm but also developed within 24 hours a very sore axilla area on the same side with swollen axillary lymph nodes in the same side. I am almost 48 hours out from the injection and the symptoms have not subsided. This did not occur with my first two doses and has never occurred with any other vaccine I have ever received.
Information has been received from a nurse concerning her 15 year old daughter with outdoor allergies (hypersensitivity) who on 31-JUL-2007 was vaccinated with varicella virus vaccine live (Oka/Merck). On 31-JUL-2007, the patient presented with a red and raised bump at the injection site. The patient sought unspecified medical attention. the patient's outcome was not reported. Additional information has been requested.
17 year old by chance gets moderna; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old by chance gets moderna) in a 17-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old by chance gets moderna). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old by chance gets moderna) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were provided by the reporter  No treatment medication were provided by the reporter   Reporter did not allow further contact
22MAR94 pt recvd vax & exp screaming & moving; 24MAR94 2" x 1" rectangular, red, swollen, tender, hot area of vax administration on lt dletoid; AM area of vax administration of lt deltoid; A: cellulitis (?);
pt recvd vax & 7 days post inject exp a h/a & earache;
I started getting migraines mid- January (a few weeks after my booster). I tried over the counter remedies, but they stopped helping and I called my Dr. Doctor on call prescribed Sumatriptan. After taking my first 2 doses and knocking my migraine out, I had a knot/bump come up on the base of my skull in my hairline that is roughly 1.5 inches wide.  Doctor on call prescribed an antibiotic after a tele-med visit. Will have a in-person follow up appt. after antibiotic. Knot is different from a muscle knot.
after taking the last dose of the COVID Vaccine, his blood pressure is no longer high, and he doesn't take medication for his blood pressure anymore; No adverse event; This spontaneous case was reported by a patient and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (after taking the last dose of the COVID Vaccine, his blood pressure is no longer high, and he doesn't take medication for his blood pressure anymore) and NO ADVERSE EVENT (No adverse event) in a male patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     The patient's past medical history included Blood pressure high.    In May 2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (after taking the last dose of the COVID Vaccine, his blood pressure is no longer high, and he doesn't take medication for his blood pressure anymore) and NO ADVERSE EVENT (No adverse event). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (after taking the last dose of the COVID Vaccine, his blood pressure is no longer high, and he doesn't take medication for his blood pressure anymore) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: Blood pressure is no longer high.         Concomitant Medication use information was not provided by reporter.  It was reported that the unexpected beneficial effect of the last dose of Moderna COVID Vaccine he got last May of this year. The caller confirmed that it was a commercial product. The caller informed that after taking the last dose of the COVID Vaccine, his blood pressure was no longer high and he did not take medication for his blood pressure anymore.  Treatment Medication use information was not provided by reporter.
This case was reported by a nurse via call center representative and described the occurrence of influenza-like symptoms in a male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved. It was unknown if the reporter considered the influenza-like symptoms to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient went on to receive the 2nd dose and reported no problems after 2nd dose. Limited information was available. The healthcare professional did not have lot or expiry.
Edema from pneumococcal vaccination in the vicinity of the injection site - left deltoid - and under armpit.
breastfeeding mother; slept 5 hours longer than usual; incredibly irritable the entire day; scream; This is a spontaneous report from a contactable consumer. This female consumer (patient mother) reported for baby that:  The patient's mother received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: FC3182), on 06Sep2021 11:00 as DOSE 1, SINGLE, And received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: 301358A), on 27Sep2021 16:00 as DOSE 2, SINGLE for covid-19 immunization. No known allergies were reported. The patients mother did not received any other medication within 4 weeks of vaccination. The patient's mother received other medications within 2 weeks of vaccination were Prenatal vitamin, magnesium, colace, DHA. Prior to vaccination, was the patients mother was  diagnosed with COVID-19. Since the vaccination, the patients mother had not been tested for COVID-19. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient was exposed via breast milk on 28Sep2021 02:00. On 28Sep2021 02:00 the patient slept for 5 hours longer than usual, and was incredibly irritable the entire day following the vaccination. They had to substitute previously pumped milk to feed him, as he would scream immediately upon drinking milk directly from my breast. This lasted for 2 days following the vaccine. At the time of reporting the outcome of the events was recovered on unspecified date in 2021.   No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101295763 mother/baby case
Severe headache, muscle pain, fever, chills, fatigue- on day 4 palms, soles of feet turn red
20 minutes after receiving vaccine,  my lips started to tingle,  face started to swell, and tongue started to swell. 30 minutes after injection started to feel short of breath and coughing. Went to ER. While in ER I started to get very red and blotchy on face and arms. Was given IV Benadryl and IV Pepcid. Monitored for 3 hours and sent home. Need to continue taking Benadryl and Pepcid.
11/19/10 After receiving MENACTRA on (R) arm next day developed arm redness & swelling with discomfort. Came into office 11/22 and was 108 X 60 light red. Seen by Dr who felt no treatment necessary.
Rash around injection site which went away after three days from the initial injection.   Muscle and joint pain all over body approximately two weeks after injection lasting for over three days and counting with a constant lethargic feeling.
Adverse effect of other vaccines and biological substances, initial encounter on 2022-06-13.
24 hours after vaccine: tiredness weakness, chills, fever, nausea, vomiting, fainted, unconscious few seconds. No medical treatment, resting at home,
Sat to remove sneakers following morning walk, stood up and felt tingling, burning sensation, numbing, pain and weakness in legs. Severe pain at night, particularly in right leg. Wakes me up, keeps me up. Blisters on lips. Nails on ring and pinky fingers (both hands) turning gradually white down to middle of nail.
This report was received from a health care professional on 28 July 2009.  A 13 year old female patient received MENACTRA (lot number U2926AA) in the left deltoid on 27 July 2009.  The patient awoke that evening feeling cold.  The next morning, the patient awoke with the following symptoms:  severe headache, chills, feeling cold, nausea, feeling achy all over, joint pain, pain in her back, knees, foot and injection site on left deltoid.  The patient also had pain in the left arm which prevented her from being able to lift it.  There was no redness or swelling of the left arm.  The patient's temperature was reported as 99.1 degrees Fahrenheit orally.  The patient's medical history includes allergies which were treated  with NASONEX and ZYRTEC.  At the time of the report, the patient was being evaluated by a health care provider.  List of documents held by sender:  none.
Very sore left arm, and on 36 hours later a blotchy red itchy rash extending  2- 4 inches from injection site. Still active 84 hrs after the injection.
Fever; Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Fatigue) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Fatigue). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Symptomatic treatment, at an unspecified dose and frequency. On 07-Mar-2021, PYREXIA (Fever) and CHILLS (Chills) had resolved. At the time of the report, FATIGUE (Fatigue) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   Reporter did not allow further contact
This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Light headedness), DECREASED APPETITE (Less or no appetite), MALAISE (Feels very sick), VOMITING (Vomiting) and CHILLS (Feeling chills) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination. Concurrent medical conditions included Blood pressure and Diabetes. On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced DIZZINESS (Light headedness), DECREASED APPETITE (Less or no appetite), MALAISE (Feels very sick), VOMITING (Vomiting) and CHILLS (Feeling chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIZZINESS (Light headedness), DECREASED APPETITE (Less or no appetite), MALAISE (Feels very sick), VOMITING (Vomiting) and CHILLS (Feeling chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant products included blood pressure pills and diabetes pill. Patient experienced the events three  hours after vaccine administration; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.
BEGAN INITIALLY AS PAIN @ SITE & ITCHING & REDNESS @ INJECTION SITE/PROGRESSED TO RED WARM TO TOUCH AREA 5CM X3 CM OVER INJECTION SITE/ NOTED 1CM BRUISE TO R OF REDDENED AREA.
Patient states that at 03:00 on 5/31/07, she had Headache, fever of 100 f, abdominal pain, and vomiting.  Called her at 11:00 on 5/31/07 and she reported that she felt a little better.  She was concerned that the symptoms were related to the vaccines she received on 5/30/07.  Advised her to call back if no improvement, or see MD, and she or husband have not called back as of this moment.
Arm is killing him today like with the other 3 injections; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE PAIN (Arm is killing him today like with the other 3 injections) in an 80-year-old male patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     Patient don't have allergies. Patient don't have medical history of  Acute and Chronic illnesses at the time of vaccination. Patient not had COVID-19 test and diagnosis. Patient not had other vaccines given within 1 month prior to Moderna COVID-19 vaccine.     On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Arm is killing him today like with the other 3 injections). At the time of the report, VACCINATION SITE PAIN (Arm is killing him today like with the other 3 injections) outcome was unknown.        mRNA-1273 (Spikevax) (Unknown) dosing remained unchanged.   For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No Concomitant Products were reported. No Treatment information was reported.   This case was linked to MOD-2022-532675, MOD-2022-532678, MOD-2022-532374 (Patient Link).
Information has been received from a nurse concerning a 19 year old female with a history of a "severe reaction to an unspecified meningitis vaccine" and no pertinent medical history who on 12-JUN-2009 was vaccinated with the first dose of GARDASIL (IM, lot number  658271/0558X).  There was no concomitant medication.  The patient experienced a fever, swelling and nausea on 18-JUN-2009, several days after the vaccination.  Unspecified medical attention was sought.  No lab/diagnostic studies were performed.  It was noted that the patient recovered 2 days after onset of symptoms, on 20-JUN-2009.  Follow-up information received from the nurse on 22-JUN-2009.  At that time the patient continued to experience headaches but her fever resolved on 19-JUN-2009.  The patient was experiencing trouble breathing.  The patient took two doses of BENADRYL and breathing improved.   The patient will not administered her second and third dose of GARDASIL.  Additional information has been requested.
pneumonia; chicken pox; Information has been downloaded from Agency (HQ4344208AUG2001).  This spontaneous report was received from a healthcare professional referring to a 13-month-old male patient. The patient's medical history, concurrent conditions, and concomitant medications were not disclosed.  On 11-JUN-2001, the patient was vaccinated with varicella virus vaccine live (oka/merck) (manufacturer unknown), administered via subcutaneous route, lot number unknown (expiration date was not reported). On that same day, he was also vaccinated with pneumococcal 4 6b 9v 14 18c 19f 23f conj vaccine (crm197) (PREVNAR) administered intramuscularly, lot number 474-947 (expiration date not provided); and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (manufacturer unknown) administered via subcutaneous route, lot number 1181K, expiration date not reported but upon internal validation was established as 27-JUL-2002. All these vaccines were administered as immunization (strengths, dose numbers, frequencies, and anatomical vaccination sites were not reported).  On 05-JUL-2001, the patient experienced pneumonia and chicken pox (herpes zoster).  On an unspecified date in July 2001, the patient had to be hospitalized due to these events.   At the reporting time, the outcomes of the events pneumonia and herpes zoster were unknown.  The causality assessment between the suspect therapies and the aforementioned events was not reported.
Hospitalization for COVID-19 on dates 6/20/2023- 6/24/2023. Treated with vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
A 52 year old female pt developed increased muscle weakness and fatigue, muscle spasms and pain on inspiration after receiving RabAvert therapy. The pt received RabAvert on the following dates: 21May04, 24May04, 28May04 and 04Jun04. Past medical history consisted of systemic lupus erythematous and hypertension. The pt also has a history of weakness, fatigue and muscle spasms at night, prior to starting RabAvert. About one month ago and prior to the 1st RabAvert injection, the pt developed pain on inspiration described as it hurt to breathe, self treated with two days of penicillin she already had at home. Concomitant medications included Plaquinil, Dextra, Spironolactone and Topral (Topral discontinued two weeks ago). The pt sustained a bite from a feral kitten and was treated with 4 out of 5 doses of RabAvert at a clinic with a fifth dose scheduled, as well as planned testing for a titer. The pt experienced increased weakness and fatigue after starting RabAvert as well as muscle spasms in her arms and legs. The weakness and fatigue are described as a rubbery, pre flu-like achiness. The muscle spasms occur occasionally and are described as not severe and like flutters. They are now occurring under the left shoulder blade and on her left side. The difficulty breathing, described as hurts to breathe, had reoccurred a few days prior to the report. An initial visit to see her rheumatologist for this problem was planned for the following day. The events had not improved at the time of this report.
2 days later patient developed nausea and vomiting and then became lethargic. The following day the patient developed backstep while walking which progressed to freezing in place and more repetitive movements.
Arm pain and numbness/ fevers for 11 days, headaches, nausea, and dizziness for 13 days
Observation 2/9/22-2/10/22 Cough, SOB, hypoxia, home O2
After shot about 15 minutes my throat starting itching and then I  started to get blotches on face and chest so I went back to the pharmacist because I was having a hard time breathing. I couldn't breathe or open my eyes so the Pharmacist had me sit then laid me down because I couldn't breath or talk. Pharmacist administered an Epi-Pen and ambulance was called.  EMT administered another Epi-Pen also gave medications for headache, some Oxygen, and I was kept overnight at Medical Hospital. I think they gave me Insulin as well. Doctor felt I may have had allergic reaction to something in Vaccine.